Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Immunoperoxidase techniques were used to obtain information about the possible presence of serum factors in senile plaques. We found only in plaques consisting of an amyloid core surrounded by a corona of degenerating neurites small amounts of IgG and light chains (kappa and lambda). These immunoglobulins were principally localized in the corona and not in the central amyloid core. Further it was found that all plaques contain the complement factors C1q, C3b, C3c, C3d and C4. Senile plaques lacked C5, C3 pro-activator and properdin. The possible significance of these findings in the genesis of the senile plaques and amyloid formation is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated microglia along with immunoglobulins and complement components are closely associated with Aβ deposits in brains from AD patients and AD mouse models (58)(59)(60)(61)(62).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [58]
Citations
Cites
Histochemistry: Theoretical and Applied
(1953) · Journal of the American Medical Association · doi:10.1001/jama.1953.02940280072039 · Cited by 7,021
ON THE BINDING OF CONGO RED BY AMYLOID
PUCHTLER, H., SWEAT, F., & LEVINE, M. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.355 · Cited by 1,128
Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration
Avrameas, S., & Ternynck, T. (1971) · Immunochemistry · doi:10.1016/0019-2791(71)90395-8 · Cited by 862
Kaplan, M. H., & Volanakis, J. E. (1974) · PubMed · Cited by 563
Glynn, L. E. (1981) · PubMed Central · Cited by 412
Interaction of C-Reactive Protein Complexes with the Complement System
Kaplan, M. H., & Volanakis, J. E. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.112.6.2135 · Cited by 405
ALZHEIMER'S DISEASE AND RELATED DISORDERS
Raskind, M. A., & Peskind, E. R. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70341-2 · Cited by 161
Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques
Ishii, T., & Haga, S. (1976) · Acta Neuropathologica · doi:10.1007/bf00685368 · Cited by 142
Ishii, T., Haga, S., & Shimizu, F. (1975) · Acta Neuropathologica · doi:10.1007/bf00689569 · Cited by 110
Research works printed but not linked: 6
- Boorsma DM, Streefkerk JG (1978) Improved method for separation of peroxidase conjugates. In: Knapp W, Holubar, K, Wick G (eds) Immunofluorescence and related staining techniques. Elsevier-North Holland Biochemical Press Amsterdam, pp 225?235
- Boorsma DM, Streefkerk JG (1976a) Some aspects of the preparation, analysis and use of peroxidase-antibody conjugates in immunohistochemistry. In: Pecters H (ed) Protides of the biological fluids, vol 24. Pergamon Press, Oxford, pp 795?802
- Davis BJ, Ornstein L (1959) High resolution enzyme localization with a new diazo reagent, ?hexazonium Pararosaniline?. J Histochem Cytochem 7:297?298
- Divry P (1927) Etude histochimique des plaques seniles. J Belge Nerol 27:643?657
- Stam FC (1965) Histochemistry of the senile involution of the brain. In: Vtn Int Congr Neuropathol Proc. Excerpta Medica, Amsterdam, pp 513?517
- Wigboldus JM (1959) Over de aard en genese van de plaques seniles. Thesis. Dijkstra's Drukkerij N.V., Groningen
Cited by
Items 401–453 of 453
Neuroinflammation: The link between periodontal disease and Alzheimer’s disease
Zisis, V., Zisis, S., Andreadis, D., & Athanasios, P. (2022) · International Journal of Applied Dental Sciences · doi:10.22271/oral.2022.v8.i1f.1455 · Cited by 1
Atomoxetine Drug Properties for Repurposing as a Candidate Alzheimer’s Disease Therapeutic Agent
Demsey, L. L., Burch, D., Lin, E., Quach, D., Podvin, S., Boyarko, B., Levey, A. I., Weinshenker, D., Edland, S. D., Galasko, D. R., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00502 · Cited by 3
Sambhariya, W. S., Rickman, C. B., D'Amore, P. A., Corradetti, G., Hageman, G. S., Howell, G. R., Marola, O. J., Phatnani, H. P., Philp, N. J., Sinha, D., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101449 · Cited by 1
Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles
Mannes, M., Zelek, W. M., & Trouw, L. A. (2026) · European Journal of Immunology · doi:10.1002/eji.70231 · Cited by 2
“…complement activation; complement proteins (e.g., C1q, C3, C5b-9) colocalize with A β plaques in Alzheimer’s disease (AD) and with drusen in AMD [ 82–85 ], driving complement-mediated tissue injury and chronic inflammation, with downstream consequences including synapse loss and neuronal injury…”
6Chapter Micronutrients for the Prevention of Diabetes and Improvement of the Standard Therapy
Prasad, K. N. (2010) · CRC Press eBooks · doi:10.1201/ebk1439821060-11 · Cited by 1
Diet, inflammation, and neurocognitive aging
Gu, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00047-0 · Cited by 1
Astrocytes and microgliain Alzheimer's disease
Barger, S. W. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31039-2 · Cited by 2
Ryu, J. Y., Yun, G., Kwon, E., Son, H. E., Kim, K., Lee, S. H., Kang, K. P., Kwon, Y. J., Chin, H. J., & On behalf of the Korean GlomeruloNEphritis sTudy (KoGNET) Group (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.238 · Cited by 1
Micronutrients for the Prevention and Improvement of the Standard Therapy for Parkinson’s Disease
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-10 · Cited by 1
Rescue of Neurons by Resolving Inflammation
Hjorth, E., & Schultzberg, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00009-0 · Cited by 1
Alzheimer’s Disease: Beyond the Neuron
Verma, A., & Zabel, M. K. (2018) · InTech eBooks · doi:10.5772/intechopen.75510 · Cited by 1
“Eikelenboom and Stam found both immunoglobulins and complement proteins resided within senile plaques using basic immunoperoxidase techniques [35].”
Neuroinflammation in Alzheimer's Disease Continuum
Sag, A. T., & Yemişçi, M. (2020) · Neurological Sciences and Neurophysiology · doi:10.4103/nsn.nsn_190_20 · Cited by 1
The Involvement of Aβ in the Neuroinflammatory Response
Eikelenboom, P., van Gool, W. A., Rozemüller, A. J. M., Scheper, W., Veerhuis, R., & Hoozemans, J. J. M. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_4 · Cited by 2
Self-citationVersijpt, J. J. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Rabbit IgG cross-reacts with Alzheimer neurofibrillary tangles
Rehman, A., Tung, Y. C., Iqbal, K., & Grundke, I. (1994) · Acta Neuropathologica · doi:10.1007/bf00294170 · Cited by 1
Glial Changes in Aging and Alzheimer’s Disease
Morán, M. A., & Gómez‐Ramos, P. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5737-1_19 · Cited by 1
Amyloid β peptide interactions with the classical pathway of complement
Webster, S. D. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_5
Masters, C. L., Martins, R. N., Simms, G., Rumble, B. A., Fuller, S. J., Hutchinson, L., Beer, J., Hilbich, C., Dyrks, T., Fischer, P. Q., et al. (1988) · Springer eBooks · doi:10.1007/978-3-642-46634-2_9
Walking With Knee Osteoarthritis
Abbasibafghi, H. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Muthuswamy, A. (2008) · UKnowledge (University of Kentucky)
Molecular and cell biological aspects of Alzheimer's ß-amyloid precursor and related proteins
van den Hurk, W. H. (2001) · Radboud Repository (Radboud University)
Role and regulation of early complement activation products in Alzheimer’s disease
Veerhuis, R., Muiswinkel, F. L. V., Hack, C. E., & Eikelenboom, P. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_3
Self-citationThe Regulation of C1 Activation and Its Role in Disease
Hack, C. E. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-017-9_2
Sarlus, H. (2015) · Figshare
Role of Complements and Immunoglobulins in Alzheimer’s Disease
Kumar, S., Mittal, R., Chaudhary, S., & Jain, D. C. (2014) · Open Journal of Applied Sciences · doi:10.4236/ojapps.2014.46028
Resolution of inflammation in Alzheimer’s disease
Wang, X. (2014) · Figshare
Ouderenpsychiatrie en de Valeriuskliniek
Eikelenboom, P. (2010) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Self-citationHaglund, M. (2005) · Lund University Publications (Lund University)
Genetic regulation of nerve injury-induced neurodegeneration and inflammation
Swanberg, M. (2007) · Figshare
Open peer commentary Inflammation and Alzheimer's disease
Akiyama, H., Barger, S. W., Barnum, S. R., Bradt, B. M., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M. R., Fiebich, B. L., et al. (2000)
Self-citationEarly lesions in Alzheimer’s diseases
Troncoso, J. C., Kawas, C. H., Pardo, C. A., & Rebolledo, F. A. (2006) · Plasticidad y Restauración Neurológica
Identification and Role of Non-Beta Components of Senile Plaque Amyloid in Alzheimer’s Disease
Takamaru, Y., Fukatsu, R., Tsuzuki, K., Chiba, H., Kobayashi, K., Nagasawa, S., Aizawa, Y., Fujii, N., Takahata, N., & Ueno, T. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_23
Alroy, G., Chapman, J., Feldon, J., & Michaelson, D. M. (1991) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1991.2.3.197
for the Treatment of Alzheimer's Disease
Aisen, P. S. S. (2002)
Lynch, M. A., & Minogue, A. M. (2014) · Arrow@dit (Dublin Institute of Technology)
Pathological Changes in the Elderly Human Brain
Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_2
Intranasal Aβ Vaccination as an Approach to Treating β-Amyloidosis
Selkoe, D. J. (2003) · Springer eBooks · doi:10.1007/978-3-642-59332-1_5
Inflammatory pathology in neurodegenerative dementias
Niedermayer, G. (2014)
Pur-alpha participates in the progression of Alzheimer's disease through direct and indirect waysPreprint
Shi, X., Ren, S., Zhang, B., Guo, S., He, W., Yuan, C., Yang, X., Ig-lzevbekhai, K., Sun, T., Wang, Q., et al. (2020) · doi:10.21203/rs.3.rs-19973/v1
“In the brains of Alzheimer's patients, complement components were detected in the amyloid core of senile plaques [49], and an increase in CR3 was”
BackgroundNeuroinflammation: 2022 update
Lassmann, H. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3790 · Cited by 2
(2007) · Elsevier eBooks · doi:10.1016/b978-012373657-4/50008-8
Pur-alpha participates in the progression of Alzheimer's disease through direct and indirect waysPreprint
Shi, X., Ren, S., Zhang, B., Guo, S., He, W., Yuan, C., Yang, X., Ig-lzevbekhai, K., Sun, T., Wang, Q., et al. (2020) · doi:10.21203/rs.3.rs-21919/v1
Ito, S., Yamauchi, K., Hama, H., Koike, M., Miyawaki, A., & Hioki, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.25.591057
“Endogenous IgG accumulation within Aβ plaques has been reported in patients with AD 33–35 .”
BackgroundProteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease
Zhu, H., Cai, M., Chen, D., Sha, J., Du, L., Chen, Y., Liu, S., Zheng, Q., Wei, X., & Bai, B. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_12
Complement mediator systems in Alzheimer’s disease
Bradt, B. M., O’Barr, S. A., Yu, J. X., & Cooper, N. R. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_4
Additional file 1 of Serum immunoglobulins and biomarkers of dementia: a population-based study
Yaqub, A., Khan, S. R., Vernooij, M. W., van Hagen, P. M., Peeters, R. P., Ikram, M. A., Chaker, L., & Dalm, V. A. S. H. (2023) · Figshare · doi:10.6084/m9.figshare.24522625
Li, M., Ma, Y.-H., Guo, Y., Liu, J.-Y., & Tan, L. (2024) · Figshare · doi:10.6084/m9.figshare.26669100
The Proteome of Human Amyloid Beta Oligomers
Kass, B., Poschmann, G., Demir, F., Huesgen, P. F., Stühler, K., Kutzsche, J., & Willbold, D. (2026) · Biochemistry · doi:10.1021/acs.biochem.5c00597 · Cited by 1
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
Pires, G. (2021) · theses.fr (ABES) · doi:10.70675/45826fd6zd2c8z4b3dz91e0za5080544cb17
Holzhausen, F., Spitzenberg, C., Pauly, D., & Baeumner, A. J. (2026) · Talanta · doi:10.1016/j.talanta.2026.130079
Correlation analysis between complement proteins and Alzheimer's disease
Lu, Y.-T., Guo, Z.-M., Liu, M.-Y., Ji, C., Luo, Y., Zhou, S.-Y., Ma, T., Zhu, X.-C., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261475358
“47 Our fi ndings indicate that reduced levels of complement proteins (C1q, C2, C3, C4a, C5, C6, C8b, and CFB) in CSF are signi fi cantly correlated with A β pathology.”
Metadata
- Authors
- Eikelenboom, P., & Stam, F. C.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- ORCID
- Eikelenboom, P.
- Venue
- Acta Neuropathologica
- Published
- 1982
- Volume
- 57
- Issue
- 2-3
- Pages
- 239-242
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2312933856
- Cited by
- 454
- References
- 24
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 23 · 2019: 13 · 2018: 13 · 2017: 11 · 2016: 9 · 2015: 7 · 2014: 16 · 2013: 7 · 2012: 11
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- amyloid plaques, Alzheimer's disease, immunoglobulins, complement proteins, amyloid core, neurite degeneration, IgG, kappa light chain, lambda light chain, C1q, C3b, C3c, C3d, C4, C5, properdin, amyloid fibril formation
- MeSH terms
- Alzheimer Disease, Amyloid, Cerebral Cortex, Complement System Proteins, Dementia, Humans, Immunoglobulin G, Immunoenzyme Techniques, Immunoglobulins, Immunoglobulin Fc Fragments, Immunoglobulin gamma-Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.